Last updated on July 2019

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes


Brief description of study

This study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D). People taking part in the study will take the medicine together with their current diabetes medicine (sulphonylurea and/or metformin). Participants will get a dose of either 1.0 mg or 2.0 mg semaglutide once a week - which dose is decided by chance. Participants will inject semaglutide under the skin once a week. The study will last for about 49 weeks. Participants will have 9 clinic visits and 2 phone calls with the study doctor. At the visits participants will have blood taken and eye tests done. Women cannot take part if pregnant, breast-feeding or planning to become pregnant during the study period. Female participants who can get pregnant will be checked 11 times for pregnancy via urine tests.

Clinical Study Identifier: NCT03989232

Find a site near you

Start Over

Novo Nordisk Investigational Site

Hawaiian Gardens, CA United States
  Connect »

Novo Nordisk Investigational Site

Los Angeles, CA United States
  Connect »

Novo Nordisk Investigational Site

Spring Valley, CA United States
  Connect »

Novo Nordisk Investigational Site

Walnut Creek, CA United States
  Connect »

Novo Nordisk Investigational Site

Colorado Springs, CO United States
  Connect »

Novo Nordisk Investigational Site

Coral Gables, FL United States
  Connect »

Novo Nordisk Investigational Site

Jacksonville, FL United States
  Connect »

Novo Nordisk Investigational Site

Adairsville, GA United States
  Connect »

Novo Nordisk Investigational Site

Lake Charles, LA United States
  Connect »

Novo Nordisk Investigational Site

Sterling Heights, MI United States
  Connect »

Novo Nordisk Investigational Site

Jefferson City, MO United States
  Connect »

Novo Nordisk Investigational Site

New Windsor, NY United States
  Connect »

Novo Nordisk Investigational Site

Statesville, NC United States
  Connect »

Novo Nordisk Investigational Site

Chattanooga, TN United States
  Connect »

Novo Nordisk Investigational Site

San Antonio, TX United States
  Connect »

Novo Nordisk Investigational Site

Shavano Park, TX United States
  Connect »

Novo Nordisk Investigational Site

Walla Walla, WA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.